Cargando…
The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin
To produce muscle fibers for cultured meat on a large scale, it is important to expand myoblasts in a serum-reduced or serum-free medium to avoid cost, ethical, and environmental issues. Myoblasts such as C2C12 cells differentiate quickly into myotubes and lose their ability to proliferate when the...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213241/ https://www.ncbi.nlm.nih.gov/pubmed/37250904 http://dx.doi.org/10.3389/fcell.2023.1193634 |
_version_ | 1785047575423877120 |
---|---|
author | Katayama, Tomoka Chigi, Yuta Okamura, Daiji |
author_facet | Katayama, Tomoka Chigi, Yuta Okamura, Daiji |
author_sort | Katayama, Tomoka |
collection | PubMed |
description | To produce muscle fibers for cultured meat on a large scale, it is important to expand myoblasts in a serum-reduced or serum-free medium to avoid cost, ethical, and environmental issues. Myoblasts such as C2C12 cells differentiate quickly into myotubes and lose their ability to proliferate when the serum-rich medium is replaced with a serum-reduced medium. This study demonstrates that Methyl-β-cyclodextrin (MβCD), a starch-derived agent that depletes cholesterol, can inhibit further differentiation of myoblasts at the MyoD-positive stage by reducing plasma membrane cholesterol on C2C12 cells and primary cultured chick muscle cells. Furthermore, MβCD efficiently blocks cholesterol-dependent apoptotic cell death of myoblasts, which is one of the mechanisms by which it inhibits the differentiation of C2C12 myoblast cells, as dead cells of myoblast are necessary for the fusion of adjacent myoblasts during the differentiation process into myotubes. Importantly, MβCD maintains the proliferative capacity of myoblasts only under differentiation conditions with a serum-reduced medium, suggesting that its mitogenic effect is due to its inhibitory effect on myoblast differentiation into myotube. In conclusion, this study provides significant insights into ensuring the proliferative capacity of myoblasts in a future serum-free condition for cultured meat production. |
format | Online Article Text |
id | pubmed-10213241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102132412023-05-27 The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin Katayama, Tomoka Chigi, Yuta Okamura, Daiji Front Cell Dev Biol Cell and Developmental Biology To produce muscle fibers for cultured meat on a large scale, it is important to expand myoblasts in a serum-reduced or serum-free medium to avoid cost, ethical, and environmental issues. Myoblasts such as C2C12 cells differentiate quickly into myotubes and lose their ability to proliferate when the serum-rich medium is replaced with a serum-reduced medium. This study demonstrates that Methyl-β-cyclodextrin (MβCD), a starch-derived agent that depletes cholesterol, can inhibit further differentiation of myoblasts at the MyoD-positive stage by reducing plasma membrane cholesterol on C2C12 cells and primary cultured chick muscle cells. Furthermore, MβCD efficiently blocks cholesterol-dependent apoptotic cell death of myoblasts, which is one of the mechanisms by which it inhibits the differentiation of C2C12 myoblast cells, as dead cells of myoblast are necessary for the fusion of adjacent myoblasts during the differentiation process into myotubes. Importantly, MβCD maintains the proliferative capacity of myoblasts only under differentiation conditions with a serum-reduced medium, suggesting that its mitogenic effect is due to its inhibitory effect on myoblast differentiation into myotube. In conclusion, this study provides significant insights into ensuring the proliferative capacity of myoblasts in a future serum-free condition for cultured meat production. Frontiers Media S.A. 2023-05-12 /pmc/articles/PMC10213241/ /pubmed/37250904 http://dx.doi.org/10.3389/fcell.2023.1193634 Text en Copyright © 2023 Katayama, Chigi and Okamura. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Katayama, Tomoka Chigi, Yuta Okamura, Daiji The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin |
title | The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin |
title_full | The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin |
title_fullStr | The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin |
title_full_unstemmed | The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin |
title_short | The ensured proliferative capacity of myoblast in serum-reduced conditions with Methyl-β-cyclodextrin |
title_sort | ensured proliferative capacity of myoblast in serum-reduced conditions with methyl-β-cyclodextrin |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213241/ https://www.ncbi.nlm.nih.gov/pubmed/37250904 http://dx.doi.org/10.3389/fcell.2023.1193634 |
work_keys_str_mv | AT katayamatomoka theensuredproliferativecapacityofmyoblastinserumreducedconditionswithmethylbcyclodextrin AT chigiyuta theensuredproliferativecapacityofmyoblastinserumreducedconditionswithmethylbcyclodextrin AT okamuradaiji theensuredproliferativecapacityofmyoblastinserumreducedconditionswithmethylbcyclodextrin AT katayamatomoka ensuredproliferativecapacityofmyoblastinserumreducedconditionswithmethylbcyclodextrin AT chigiyuta ensuredproliferativecapacityofmyoblastinserumreducedconditionswithmethylbcyclodextrin AT okamuradaiji ensuredproliferativecapacityofmyoblastinserumreducedconditionswithmethylbcyclodextrin |